KR20220084109A - 항암제 노출 방지 방법 - Google Patents

항암제 노출 방지 방법 Download PDF

Info

Publication number
KR20220084109A
KR20220084109A KR1020227016126A KR20227016126A KR20220084109A KR 20220084109 A KR20220084109 A KR 20220084109A KR 1020227016126 A KR1020227016126 A KR 1020227016126A KR 20227016126 A KR20227016126 A KR 20227016126A KR 20220084109 A KR20220084109 A KR 20220084109A
Authority
KR
South Korea
Prior art keywords
solution
hypochlorous acid
anticancer
aqueous solution
test
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020227016126A
Other languages
English (en)
Korean (ko)
Inventor
치에코 야마시타
유이치 나카지마
Original Assignee
프로그래스 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프로그래스 가부시키가이샤 filed Critical 프로그래스 가부시키가이샤
Publication of KR20220084109A publication Critical patent/KR20220084109A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A62—LIFE-SAVING; FIRE-FIGHTING
    • A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
    • A62D3/00—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances
    • A62D3/30—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by reacting with chemical agents
    • A62D3/38—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by reacting with chemical agents by oxidation; by combustion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/01—Deodorant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/14—Disinfection, sterilisation or deodorisation of air using sprayed or atomised substances including air-liquid contact processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2101/00—Chemical composition of materials used in disinfecting, sterilising or deodorising
    • A61L2101/02—Inorganic materials
    • A61L2101/06—Inorganic materials containing halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2209/00—Aspects relating to disinfection, sterilisation or deodorisation of air
    • A61L2209/10—Apparatus features
    • A61L2209/13—Dispensing or storing means for active compounds
    • A61L2209/132—Piezo or ultrasonic elements for dispensing

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Business, Economics & Management (AREA)
  • Emergency Management (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020227016126A 2019-11-11 2020-11-09 항암제 노출 방지 방법 Ceased KR20220084109A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2019-203722 2019-11-11
JP2019203722 2019-11-11
PCT/JP2020/041778 WO2021095696A1 (ja) 2019-11-11 2020-11-09 抗がん剤曝露防止方法

Publications (1)

Publication Number Publication Date
KR20220084109A true KR20220084109A (ko) 2022-06-21

Family

ID=75912915

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227016126A Ceased KR20220084109A (ko) 2019-11-11 2020-11-09 항암제 노출 방지 방법

Country Status (5)

Country Link
JP (1) JPWO2021095696A1 (cg-RX-API-DMAC7.html)
KR (1) KR20220084109A (cg-RX-API-DMAC7.html)
CN (1) CN114728189A (cg-RX-API-DMAC7.html)
TW (1) TW202123978A (cg-RX-API-DMAC7.html)
WO (1) WO2021095696A1 (cg-RX-API-DMAC7.html)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6117973B2 (cg-RX-API-DMAC7.html) 1977-04-07 1986-05-10 Kajima Corp
US6092445A (en) 1999-04-29 2000-07-25 Skackelford; Jerry Lynn Telescoping die holder
JP2014217555A (ja) 2013-05-08 2014-11-20 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinsonand Company 輸液チューブセットおよびその使用方法
KR20180122023A (ko) 2016-03-28 2018-11-09 어플라이드 머티어리얼스, 인코포레이티드 서셉터 지지부
KR20180126316A (ko) 2017-05-17 2018-11-27 엘지전자 주식회사 스마트 비데 및 이를 포함하는 제어 시스템

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9323399D0 (en) * 1993-11-12 1994-01-05 Univ Newcastle Ventures Ltd Pharmaceutical formulations
DE69840706D1 (de) * 1997-11-11 2009-05-14 Takara Bio Inc Arzneimittel, speisen oder getränke mit physiologisch aktiven stoffen aus algen
JP2003169842A (ja) * 2001-12-04 2003-06-17 Sony Corp 次亜塩素酸水溶液による殺菌方法および殺菌装置
MXPA04009412A (es) * 2002-03-28 2005-12-12 Oxis Int Inc Metodos neuroprotectores, composiciones y metodos para seleccion de los mismos.
JP2006081802A (ja) * 2004-09-17 2006-03-30 Technomax:Kk 次亜塩素酸含有水による悪臭物質収容施設の殺菌・消臭方法及びそれに用いる装置
TW200714276A (en) * 2005-10-12 2007-04-16 Chiayi University Method for producing anti-tumor compound, piceatannol
WO2010148004A1 (en) * 2009-06-15 2010-12-23 Oculus Innovative Sciences, Inc. Solution containing hypochlorous acid and methods of using same
EP2558156B1 (en) * 2010-04-14 2017-11-01 Hypo-Stream Limited Device for preparing dilute disinfectant solution
JP5613900B2 (ja) * 2010-10-27 2014-10-29 学校法人 岩手医科大学 光触媒水性組成物及び該組成物を用いた抗がん剤分解法
JP3166522U (ja) * 2010-12-24 2011-03-10 ナナイロ株式会社 除菌消臭用噴霧器
WO2014208428A1 (ja) * 2013-06-25 2014-12-31 株式会社タムラテコ 抗がん剤分解方法および抗がん剤分解装置
JP2018516964A (ja) * 2015-06-09 2018-06-28 サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッドSun Pharma Advanced Research Company Limited 局所進行性または転移性である肝内もしくは肝外胆管または胆嚢のカルシノーマに罹患する患者を治療する方法
JP2020174900A (ja) * 2019-04-18 2020-10-29 緒方 康夫 抗癌剤を分解するための薬剤および方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6117973B2 (cg-RX-API-DMAC7.html) 1977-04-07 1986-05-10 Kajima Corp
US6092445A (en) 1999-04-29 2000-07-25 Skackelford; Jerry Lynn Telescoping die holder
JP2014217555A (ja) 2013-05-08 2014-11-20 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinsonand Company 輸液チューブセットおよびその使用方法
KR20180122023A (ko) 2016-03-28 2018-11-09 어플라이드 머티어리얼스, 인코포레이티드 서셉터 지지부
KR20180126316A (ko) 2017-05-17 2018-11-27 엘지전자 주식회사 스마트 비데 및 이를 포함하는 제어 시스템

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
비특허문헌 1: 일반 사단법인 일본 암 간호학회, 공익 사단법인 일본 임상 종양 학회, 일반 사단법인 일본 임상 종양 약학회 공동편찬, "암 약물 요법에 있어서의 노출 대책 합동 가이드라인 2015년판", 가네하라 출판 주식회사, 2015년 10월 15일 발행, P. 66-68

Also Published As

Publication number Publication date
TW202123978A (zh) 2021-07-01
WO2021095696A1 (ja) 2021-05-20
JPWO2021095696A1 (cg-RX-API-DMAC7.html) 2021-05-20
CN114728189A (zh) 2022-07-08

Similar Documents

Publication Publication Date Title
US20050186135A1 (en) Compositions, methods, apparatuses, and systems for singlet oxygen delivery
CA2765696C (en) Solution containing hypochlorous acid and methods of using same
CN101107018B (zh) 消毒剂系统
KR101532778B1 (ko) 산화 환원 전위 수용액을 사용한 2도 및 3도 화상의 치료방법
KR20080011312A (ko) 치과용 용도에서 산화 환원 전위 수용액의 사용 방법
KR20130092977A (ko) 희석된 소독제 용액을 제조하기 위한 장치
Roussin et al. Assessment of workplace environmental contamination and occupational exposure to cisplatin and doxorubicin aerosols during electrostatic pressurized intraperitoneal aerosol chemotherapy
US20210352905A1 (en) Compositions and methods to disinfect, treat and prevent microbial infections
WO2021095696A1 (ja) 抗がん剤曝露防止方法
US20020098246A1 (en) Compositions, methods, apparatuses, and systems for singlet oxygen delivery
JP2020174900A (ja) 抗癌剤を分解するための薬剤および方法
KR20010052418A (ko) 약제용액 조제장치
JP2024064799A (ja) 抗がん剤分解液及びこれを用いた抗がん剤分解方法
JP2024090489A (ja) 抗がん剤分解液
JP7012065B2 (ja) 即効性抗がん剤分解剤及び即効性抗がん剤分解方法
EP1353679A2 (en) Compositions, methods and apparatuses for singlet oxygen delivery
US20110077572A1 (en) Medical Equipment and Products using Chlorine, Hydrogen Peroxide, and Anti-Viral, Anti-Bacterial, Anti-Fungal, Agents, usage Method Improvements Dread Disease Cures, Remissions, and Anti-Infective Treatment Measures, Disease Treatment and Prevention System
WO2021029347A1 (ja) 抗がん剤分解剤及び抗がん剤分解方法
EP3534809B1 (de) Débridement-vorrichtung
JP3235230U (ja) 悪臭等防止用パイプ装着おむつ
Derry Iodine: the forgotten weapon against influenza viruses
Turek Chemotherapy safety in small animal practice: what you need to know to protect yourself, your patient and your clients.
Dobson Chemotherapy Protocols and Safety
Unda-Urzáiz et al. Review of evidence on handling hazardous drugs and Products in Urology Services; consensus document between the Spanish Urology Association and the Spanish Society of Health-System Pharmacists
Grigorescu Rules for the manipulation of cytostatic agents used in cancerous disease.

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20220513

Patent event code: PA01051R01D

Comment text: International Patent Application

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20250115

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20250325

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D